ACGT Awards Luncheon Honors Crystal Mackall, MD, With Edward Netter Leadership Award

Article

Alliance for Cancer Gene Therapy (ACGT) awarded The Edward Netter Leadership Award to Crystal Mackall, MD, of Stanford University.

Alliance for Cancer Gene Therapy (ACGT) awarded The Edward Netter Leadership Award to Crystal Mackall, MD, of Stanford University, at the ACGT Awards Luncheon on March 30 at Riverpark restaurant at the Alexandria Center for Life Science in New York City.

Crystal Mackall, MD Edward Netter Leadership Award | Image Credit: ACGT

Crystal Mackall, MD, right, received The Edward Netter Leadership Award during the ACGT Awards Luncheon earlier this year. Carl June, MD, left, the 2019 recipient of the award, presented it to Dr. Mackall.

The ACGT Awards Luncheon celebrated the non-profit organization’s 20th anniversary and ushered in a new decade. The event was held during the intermission of the ACGT Summit 2023.

Attendees, including scientists and donors, helped ACGT recognize Dr. Mackall for her incredible achievements, such as the numerous groundbreaking clinical trials she has led to treat children with sarcomas and brain cancers. Named for ACGT co-founder, Edward Netter, the award recognizes a researcher who has made unparalleled and groundbreaking contributions to the field of cell and gene therapy for cancer.

“Without the donors, Alliance for Cancer Gene Therapy doesn’t exist,” Dr. Mackall said, later adding that “you get (a foundation like ACGT) by having a leadership with great instincts, leadership that is passionate, and leadership that has grit.”

Read more about Dr. Mackall’s recognition and the ACGT Awards Luncheon on the foundation’s website.

Recent Videos
Manali Kamdar, MD, on Liso-Cel's Ongoing Benefit in the Treatment Lanscape for LBCL
Manali Kamdar, MD, on The Importance of Bringing Liso-Cel to Earlier Lines of Lymphoma Treatment
Lisa Nieland on Slowing Tumor Growth in Glioblastoma With Novel AAV Therapy
Manali Kamdar, MD, on Acclimating to Routine CAR T Practice in the Field
Manali Kamdar, MD, on Evaluating Liso-Cel in Mantle Cell Lymphoma by Lines of Therapy, Prior BTKi
Manali Kamdar, MD, on Bringing Liso-Cel to Earlier Lines of Treatment
Omid Hamid, MD, on Assessing TIL Combination Therapies, Expanding Past Melanoma
Sowmya Viswanathan, PhD, on Translating Cell Therapies to the Clinic at ISCT 2024
Omar Nadeem, MD, on Initial Efficacy of GPRC5D-CAR in R/R Multiple Myeloma
David Suhy, PhD, the cofounder and chief scientific officer of Earli
© 2024 MJH Life Sciences

All rights reserved.